New
PURILAX DEEP - Cross-Linked Hyaluronic Acid - 1.1ml
AETERDERM PURILAX Deep
Professional Monophasic Cross-Linked Hyaluronic Acid Dermal Filler with Lidocaine
PURILAX Deep is a professional monophasic cross-linked Hyaluronic Acid dermal filler developed for medical aesthetic professionals seeking a cohesive, smooth and durable HA gel for mid-dermal correction and enhancement.
Each 1.1 mL pre-filled syringe contains 24 mg/mL cross-linked Hyaluronic Acid combined with 0.3 mg/mL Lidocaine HCl.
PURILAX Deep is positioned as the medium-depth formulation within the PURILAX family and is designed for mid-dermis placement.
Soft, Uniform and Cohesive Monophasic HA Gel
PURILAX is engineered around a uniform cross-linked Hyaluronic Acid matrix designed to provide controlled viscoelasticity, cohesivity and plasticity for predictable professional aesthetic correction.
PURILAX is engineered around a uniform cross-linked Hyaluronic Acid matrix designed to provide controlled viscoelasticity, cohesivity and plasticity for predictable professional aesthetic correction.
Advanced Monophasic HA Technology
PURILAX utilizes a specialized manufacturing process designed to produce a soft and uniform cross-linked Hyaluronic Acid gel.
According to the PURILAX professional brochure, the formulation is characterized by stable and uniform cross-linking, optimized viscoelasticity, high cohesivity and flexible plasticity.
These rheological properties are important to the performance of an HA filler because they influence product integration, shape maintenance, extrusion characteristics and the ability of the gel to adapt naturally within treated tissue.
High Viscoelasticity
Hyaluronic Acid helps increase moisture retention and supports collagen-related skin properties while contributing to flexibility and volume.
The PURILAX formulation is engineered with viscoelastic characteristics designed to support effective volume maintenance and durable aesthetic correction.
Optimized Cohesivity
PURILAX is designed with a cohesive monophasic matrix that supports homogeneous integration within tissue.
The formulation's cohesivity is intended to support smooth distribution and natural-looking aesthetic results while maintaining structural integrity.
Flexible Plasticity
Flexible plasticity allows the gel to adapt to the contours of the treatment area while supporting controlled shaping and professional correction.
The combination of cohesivity, viscoelasticity and plasticity is designed to provide aesthetic professionals with a balanced HA filler for predictable tissue integration and natural-looking outcomes.
Smooth and Consistent Extrusion
PURILAX is engineered to provide consistent extrusion force, supporting smooth and controlled administration during professional treatment.
Professional Treatment Applications
According to the PURILAX professional treatment guide, PURILAX Deep may be incorporated into professionally assessed protocols addressing:
- Nasolabial Folds
- Frown Lines
- Lip Enhancement
- Chin Enhancement and Contouring
- Nasal Contouring / Rhinoplasty Applications
Key Professional Features
-
24 mg/mL Cross-Linked Hyaluronic Acid
Professional-strength HA concentration within a cohesive monophasic gel matrix. -
0.3 mg/mL Lidocaine HCl
Lidocaine is incorporated directly into the formulation. -
Monophasic Gel Technology
Designed to provide a smooth and uniform cross-linked Hyaluronic Acid matrix. -
Mid-Dermis Placement
PURILAX Deep is specifically positioned for professional mid-dermal aesthetic applications. -
High Cohesivity
Supports homogeneous tissue integration and controlled product distribution. -
Optimized Viscoelasticity
Designed to provide an effective balance between flexibility, support and volume maintenance. -
Flexible Plasticity
Supports controlled shaping and adaptation to facial contours. -
Consistent Extrusion Force
Engineered for smooth and convenient professional administration.
Product Information
| Product | AETERDERM PURILAX Deep |
|---|---|
| Product Category | Professional HA Dermal Filler |
| Gel Type | Monophasic |
| Cross-Linked HA | 24 mg/mL |
| Lidocaine HCl | 0.3 mg/mL |
| Syringe Volume | 1.1 mL |
| Injection Depth | Mid Dermis |
| Injection Force | Approximately 220 - 240 Pa |
| Storage Modulus (G') | 150 - 200 G' |
| Complex Viscosity | 200 - 300 Pa |
| Duration | 12 Months |
| Included Needle Gauge | 2 x 27G x 1/2" |
| Package | 1 Pre-Filled Syringe / Box |
For Professionals Only
If you already have a Dermafirm professional account, please log in to view professional purchasing options and proceed to checkout.
If you have not yet registered, you can apply for a Dermafirm professional account using the link below.
Professional Treatment Protocol
PURILAX Deep is a ready-to-use monophasic cross-linked Hyaluronic Acid dermal filler designed for professional mid-dermis placement.
Step 1: Professional Assessment
Conduct a comprehensive patient consultation and anatomical assessment before treatment.
Evaluate facial anatomy, tissue characteristics, treatment history, degree of correction required and the patient's aesthetic objectives before developing the treatment plan.
Step 2: Select the Treatment Area
The PURILAX professional guide identifies PURILAX Deep for professionally assessed treatment of areas including:
- Nasolabial folds
- Frown lines
- Lip enhancement
- Chin enhancement and contouring
- Nasal contouring / rhinoplasty applications
Step 3: Prepare the Treatment Area
Thoroughly cleanse and prepare the selected treatment area according to established professional dermal-filler protocols.
Step 4: Prepare the Prefilled Syringe
PURILAX Deep is supplied as a ready-to-use 1.1 mL pre-filled syringe and does not require reconstitution.
The PURILAX Deep package includes two 27G x 1/2" needles.
Prepare the syringe and selected needle according to the official product instructions and established professional technique.
Step 5: Mid-Dermis Placement
PURILAX Deep is designed for mid-dermis injection depth.
Determine the appropriate administration technique, injection volume, distribution pattern and degree of correction according to the patient's anatomy, selected treatment area and desired aesthetic result.
Step 6: Assess and Complete Treatment
Following administration, evaluate product distribution, contour, symmetry and the degree of correction achieved.
Complete the procedure according to the treating professional's established HA filler protocol and provide individualized post-treatment instructions.
PURILAX Deep Professional Profile
Injection Depth: Mid Dermis
Included Needles: 2 x 27G x 1/2"
Syringe Volume: 1.1 mL
Gel Type: Monophasic
Injection Depth: Mid Dermis
Included Needles: 2 x 27G x 1/2"
Syringe Volume: 1.1 mL
Gel Type: Monophasic
Ingredients / Composition
Cross-Linked Hyaluronic Acid - 24 mg/mL
PURILAX Deep contains 24 mg/mL of cross-linked Hyaluronic Acid.
Hyaluronic Acid is formulated into a monophasic cross-linked gel designed to provide the viscoelasticity, cohesivity and plasticity required for professional dermal-filler applications.
Lidocaine HCl - 0.3 mg/mL
PURILAX Deep contains 0.3 mg/mL Lidocaine HCl incorporated directly into the formulation.
Phosphate-Buffered Saline
The formulation contains phosphate-buffered saline, q.s. as identified in the official PURILAX composition.
Declared Composition
| Cross-Linked Hyaluronic Acid | 24 mg/mL |
|---|---|
| Lidocaine HCl | 0.3 mg/mL |
| Phosphate-Buffered Saline | q.s. |
| Syringe Volume | 1.1 mL |
| Product Form | Monophasic Cross-Linked HA Gel |
| Package Unit | 1 Pre-Filled Syringe + 2 Needles / Box |
PURILAX Deep Professional Composition
Cross-Linked Hyaluronic Acid: 24 mg/mL
Lidocaine HCl: 0.3 mg/mL
Phosphate-Buffered Saline: q.s.
Pre-Filled Syringe: 1.1 mL
Cross-Linked Hyaluronic Acid: 24 mg/mL
Lidocaine HCl: 0.3 mg/mL
Phosphate-Buffered Saline: q.s.
Pre-Filled Syringe: 1.1 mL